Biotechnology has become one of the markets with more growth potential in the next years. To the development of new technologies allowing a broad spectrum of new applications, we have to add circumstances like the COVID-19 health crisis.
At the core of this coming revolution there is one technology: Genome Assembly. This is the fundamental technology making possible the products that are emerging for markets like personalized health or DNA engineering in the agricultural sector. And at the core of Genome Assembly there is the software for Genome Assembly: an essential tool due to the inherent difficulty of the problem to solve. A Genome Assembly machine is useless without that software, and a software that is more efficient than other ones provides a strategic advantage to all the products derived in the chain.
Contignant Technologies has developed the genome-assembly software with the best metrics and features in the market. We can save time and money to all these industrial sectors and therefore, we think we have a product that is a must for the tens of thousands of biology research labs in the world which are actually expending around $6Bn in bioinformatics products and services with a15% of market growth every year. This a great opportunity for becoming a major player in a very strategic market for the future economy. more